Characterizing Regions of Hypoperfusion and Restricted Diffusion in Head and Neck Cancer Patients Enrolled on a Prospective Phase 2 Randomized Trial

International Journal of Radiation Oncology Biology Physics - Netherlands
doi 10.1016/j.ijrobp.2016.06.181
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Racial Disparity in Oncologic and Quality-Of-Life Outcomes in Patients With Locally Advanced Head and Neck Squamous Cell Carcinomas Enrolled in a Randomized Phase 2 Trial

Cancer
Cancer ResearchOncology
2018English

A Randomized Phase III Prospective Trial of Bethanechol to Prevent Mucositis, Candidiasis, and Taste Loss in Patients With Head and Neck Cancer Undergoing Radiotherapy: A Secondary Analysis

Journal of oral science
MedicineDentistry
2009English

Using Low-Dose Radiation to Potentiate the Effect of Induction Chemotherapy in Head and Neck Cancer: Results of a Prospective Phase 2 Trial

Advances in Radiation Oncology
Nuclear MedicineRadiologyImagingOncology
2016English

Randomized Double-Blind Trial of Amifostine Versus Placebo for Radiation-Induced Xerostomia in Patients With Head and Neck Cancer

Journal of Medical Imaging and Radiation Oncology
OncologyRadiologyNuclear MedicineImaging
2018English

Psychosomatic Studies on Head and Neck Cancer Patients.

Practica Otologica
Otorhinolaryngology
1987English

Eating as Treatment: A Stepped Wedge Randomized Controlled Trial to Improve Nutrition in Head and Neck Cancer Patients Undergoing Radiation Therapy

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2017English

Clinical Trial of Nintedanib in Patients With Recurrent or Metastatic Salivary Gland Cancer of the Head and Neck: A Multicenter Phase 2 Study (Korean Cancer Study Group HN14-01)

Cancer
Cancer ResearchOncology
2017English

A Phase 2 Randomized Trial of Apremilast in Patients With Atopic Dermatitis

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2019English

ERCC1 Is a Prognostic Biomarker in Locally Advanced Head and Neck Cancer: Results From a Randomised, Phase II Trial

British Journal of Cancer
Cancer ResearchOncology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy